BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $4,274,098 | +7.0% | 83,400 | +13.0% | 1.15% | -3.7% |
Q3 2022 | $3,995,000 | +6.4% | 73,800 | +26.8% | 1.20% | +9.6% |
Q2 2022 | $3,755,000 | -11.6% | 58,208 | +6.2% | 1.09% | +5.0% |
Q1 2022 | $4,250,000 | -3.3% | 54,808 | +7.0% | 1.04% | -14.0% |
Q4 2021 | $4,396,000 | +14.3% | 51,208 | +7.1% | 1.21% | +1.0% |
Q3 2021 | $3,845,000 | +384400.0% | 47,808 | +597500.0% | 1.20% | – |
Q2 2021 | $1,000 | -100.0% | 8 | -100.0% | 0.00% | -100.0% |
Q1 2021 | $3,822,000 | +8.7% | 45,315 | +3.5% | 1.39% | -3.3% |
Q4 2020 | $3,515,000 | +16.5% | 43,800 | +16.8% | 1.44% | -9.6% |
Q3 2020 | $3,016,000 | +0.7% | 37,500 | +7.8% | 1.59% | -6.5% |
Q2 2020 | $2,996,000 | +37350.0% | 34,800 | +34700.0% | 1.70% | +33900.0% |
Q1 2020 | $8,000 | -99.7% | 100 | -99.7% | 0.01% | -99.7% |
Q2 2019 | $2,670,000 | -0.8% | 32,600 | -1.5% | 1.58% | -6.5% |
Q1 2019 | $2,691,000 | +34.5% | 33,100 | +8.9% | 1.69% | +23.0% |
Q4 2018 | $2,001,000 | +1625.0% | 30,400 | +1926.7% | 1.38% | +1710.5% |
Q3 2018 | $116,000 | +4.5% | 1,500 | 0.0% | 0.08% | -2.6% |
Q2 2018 | $111,000 | +13.3% | 1,500 | 0.0% | 0.08% | +6.8% |
Q1 2018 | $98,000 | +1.0% | 1,500 | 0.0% | 0.07% | -2.7% |
Q4 2017 | $97,000 | – | 1,500 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |